Ministry licences three domestically-produced Molnupiravir drugs to treat COVID-19
The Drug Administration of Vietnam (DAV) under the Ministry of Health on February 17 issued the list of three COVID-19 treatment drugs containing the active ingredient Molnupiravir, which had been granted certificates of registration for conditional circulation.
Hanoi (VNA) – The Drug Administration of Vietnam (DAV) under the Ministryof Health on February 17 issued the list of three COVID-19 treatment drugs containing the active ingredient Molnupiravir, which had been granted certificates of registration for conditional circulation.
The three drugs are Molravir 400 produced by Boston Vietnam Pharma; Movinavir 200 mg manufactured by Mekophar Chemical Pharmaceutical; and Molnupiravir Stella400 produced by Stellapharm J.V Co., Ltd.
Earlier, the advisory council of the Ministry of Health agreed with the latter's proposal on granting certificates of registration for conditional circulation to the three drugs. The licensing for these drugs is valid for three years fromthe date of signing the decision.
The DAV requested drug manufacturing and registration establishments to producein accordance with dossiers and documents registered with the Ministry of Health, coordinate with treatment facilities tostrictly comply with current regulations on prescription drugs, monitor thesafety, effectiveness, and unwanted effects of drugs on Vietnamese people, and reportit regularly.
The DAV also asked the Departments of Health of provincesand centrally-run cities to direct local medical examination and treatmentfacilities, medical staff, and drug supply establishments to notify patients ofthe benefits and risks when using these drugs, treatment methods, other drugsthat can replace Molnupiravir in treating COVID-19.
During the circulation of the three drugs, based on the monitoring and updating information on the safety and effectiveness of them,the agency may decide to revoke the granted certificates of registration for circulation in line with Clause 1, Article 58 of the Law on Pharmacy./.
About 490,000 children in Vietnam were confirmed to have contracted the COVID-19 since the beginning of the pandemic, according to Deputy Health Minister Nguyen Truong Son.
Deputy Prime Minister Vu Duc Dam requested the Ministry of Health to soon issue guidance on COVID-19 testing at school and for health monitoring of children with illnesses or underlying health conditions, at an online meeting with representatives of the 63 provinces and cities held on February 17.
The number of COVID-19 cases detected in the past 24 hours from 4pm February 16 to 4pm February 17 rose by 1,467 from the previous day to 36,200, including 10 imported cases, according to the Ministry of Health.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Illustrative image (Source: covid19.gov.vn) 
